Stay updated with breaking news from Procaps Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Procaps Group S.A. (NASDAQ:PROC – Get Rating) shares fell 4.1% during trading on Monday . The stock traded as low as $4.70 and last traded at $4.70. 7,868 shares traded hands during trading, a decline of 77% from the average session volume of 33,751 shares. The stock had previously closed at $4.90. Procaps Group Price […]
Procaps Group S.A. (NASDAQ:PROC – Get Rating) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 133,100 shares, a decrease of 30.9% from the March 15th total of 192,500 shares. Based on an average daily volume of 35,000 shares, the […]
Procaps Group S.A. (NASDAQ:PROC – Get Rating) traded up 6.9% during mid-day trading on Thursday . The stock traded as high as $4.96 and last traded at $4.96. 4,409 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 34,781 shares. The stock had previously closed at $4.64. Procaps […]
Shares of Procaps Group S.A. (NASDAQ:PROC – Get Rating) gapped down prior to trading on Monday . The stock had previously closed at $4.87, but opened at $4.51. Procaps Group shares last traded at $4.54, with a volume of 1,574 shares changing hands. Procaps Group Stock Performance The company has a 50-day moving average of […]
Procaps Group (NASDAQ:PROC – Get Rating) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk. Earnings and Valuation This table compares Procaps Group and […]